Circulating miR-200c Levels Significantly Predict Response to Chemotherapy and Prognosis of Patients Undergoing Neoadjuvant Chemotherapy for Esophageal Cancer

Author： Tanaka Koji   Miyata Hiroshi   Yamasaki Makoto   Sugimura Keijiro   Takahashi Tsuyoshi   Kurokawa Yukinori   Nakajima Kiyokazu   Takiguchi Shuji   Mori Masaki   Doki Yuichiro  

Publisher： Springer Publishing Company

ISSN： 1068-9265

Source： Annals of Surgical Oncology, Vol.20, Iss.3, 2013-12, pp. : 607-615

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Methylated DNA and high total DNA levels in the serum of patients with breast cancer following neoadjuvant chemotherapy are predictive of a poor prognosis

By                        

Oncology Letters, Vol. 8, Iss. 1, 2014-01 ,pp. : 397-403

Spandidos Publications

Access to resources Recommend Favorite

Tumor-Infiltrating Lymphocytes Predict Response to Neoadjuvant Chemotherapy in Patients with Breast Carcinoma

By Hornychova Helena   Melichar Bohuslav   Tomsova Marketa   Mergancova Jindøiska   Urminska Hana   Ryska Ales  

Cancer Investigation, Vol. 26, Iss. 10, 2008-12 ,pp. : 1024-1031

Informa Healthcare

Access to resources Recommend Favorite

High circulating miR‐18a, miR‐20a, and miR‐92a expression correlates with poor prognosis in patients with non‐small cell lung cancer

By  

Cancer Medicine, Vol. 7, Iss. 1, 2018-01 ,pp. : 21-31

John Wiley & Sons Inc

Access to resources Recommend Favorite

Neoadjuvant chemotherapy in young breast cancer patients: correlation between response and relapse?

By Braud A.C.   Asselain B.   Scholl S.   De La Rochefordiere   Palangie T.   Dieras V.   Pierga J.Y.   Dorval T.   Jouve M.   Beuzeboc P.   Pouillart P.  

European Journal of Cancer, Vol. 35, Iss. 3, 1999-03 ,pp. : 392-397

Elsevier

Access to resources Recommend Favorite

HER-2/Neu overexpression does not predict response to neoadjuvant chemotherapy or prognosticate survival in patients with locally advanced breast cancer

By Tulbah Asma   Ibrahim Ezzeldin   Ezzat Adnan   Ajarim Dahish   Rahal Mohammed   Weshi Amr   Sorbris Ralph  

Medical Oncology, Vol. 19, Iss. 1, 2002-03 ,pp. : 15-23

Humana Press, Inc

Access to resources Recommend Favorite